Not checkedNot checked for notices yet.
Mirtron-mediated RNA knockdown/replacement therapy for the treatment of dominant retinitis pigmentosa
Harry O. Orlans, Michelle E. McClements, Alun R. Barnard and 2 more
Nature Communications · 2021
doi:10.1038/s41467-021-25204-3 (opens in a new tab)
We email you when a new notice or a question about this paper appears.
Abstract
Rhodopsin-related dominant retinitis pigmentosa is a degenerative disease of the retina of the eye for which there is no current treatment. In this study, the authors use a novel form of RNA-interference- artificial mirtrons- to slow retinal degeneration in a mouse model of the disease.
Abstract licence: CC BY-NC-ND
Reads
Read by people on this page
None yet.
Checked or read by AI through naulon
None yet.
A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.
Are you an author?
Is this your paper?
Claim it to add your note and be paid when agents cite it. Free.